cerrar
Tagged with Switzerland,

Interview: Martin Rohrbach – Partner & Head of Life…
Patient-driven drug pricing, the uncertain future of Switzerland’s tax regime, and new business models for life science innovators in a changing…

Interview: Orlando Oliveira – SVP and General Manager…
Well-funded and with a stellar pipeline, TESARO is an up and coming Boston-based oncology biotech ready to launch their two first products in the…

Interview: Antonio Pusole – General Manager, ALK…
Recently arrived from Germany, ALK’s new general manager for Switzerland highlights some of the unique features of the Swiss allergology field, and…

Interview: Christian Beltrametti – CEO, Linnea, Switzerland
With 35 years’ experience in natural extracts, purified ingredients, semi-synthetic APIs of natural origin and manufacturing products to the highest…

Interview: Roger Hunziker – Country Sales Director; Martin…
Working at the convergence of information technology and operational technology, Rockwell helps clients to unlock value by giving them the right data…

Interview: Philippe Hügli – Country Coordinator, Boston…
Working to stay ahead in the highly competitive medical device field, Boston Scientific’s Philippe Hügli launched a Customer Insight Initiative in…

Interview: Thierry Volle – President EMEA, Lupin
Lupin’s EMEA President Thierry Volle explains that to fuel growth in the EMEA region, Lupin is investing heavily in transforming the business from a…

Interview: Michele Genovesi – Group Head of Business…
Soho Flordis International (SFI) has the ambition to be a global leader in premium natural healthcare solutions, and is leveraging extensive M&A…

Interview: Stefano Rizzi – Director of the Economic…
Italian-speaking Swiss canton Ticino outperforms most regions within Europe, yet still lags behind the high-flying cantons of Northern Switzerland.…

Interview: Giorgio Calderari – Chairman, Farma Industria…
With a population of only 350,000, Ticino has a remarkably well developed pharmaceutical cluster. FIT Chairman Giorgio Calderari explains that the…

Interview: Piero Poli – President & CEO, Rivopharm,…
Niche generics manufacturer Rivopharm was nearly bankrupt when acquired by current president and CEO Piero Poli in 2005; he explains the changes and…

Interview: Konstantin Matentzoglu – CEO, Celonic,…
www.celonic.com CEO of Swiss biologics CDMO Celonic, Konstantin Matentzoglu, explains how the company attracts talented and experienced staff and…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here